secwatch.observer — SEC 8-K summary
======================================

Issuer:     Solventum Corp (SOLV)
CIK:        0001964738
Form:       8-K
Filed at:   2025-08-22T23:59:59+00:00
Accession:  0001964738-25-000073
Event type: debt
Sentiment:  neutral
Materiality: 0.60
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Solventum commences $1.75B note tender offers contingent on Thermo Fisher deal proceeds
--------------------------------------------------------------------------------

- Up to $1.75B aggregate purchase price: Pool 1 ($1.25B) covers 2027-2031 notes, Pool 2 ($500M) covers 2054 & 2064 notes.
- 2027 Notes have $500M sublimit; early tender payment of $30 per $1,000 principal for all series.
- Condition: Solventum must receive and repatriate proceeds from sale of purification & filtration business to Thermo Fisher (announced June 25, 2025).
- Tender offers expire Sept 22, 2025; early tender deadline Sept 5, 2025; early settlement expected Sept 10, 2025.
- Lead dealer managers: J.P. Morgan, Morgan Stanley, Barclays, Goldman Sachs.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1964738/000196473825000073/0001964738-25-000073-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1964738/000196473825000073/solv-20250822.htm
  HTML page:      https://secwatch.observer/filing/0001964738-25-000073

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer